Is Avadel Pharmaceuticals PLC halal to invest in?

As of July 2026, Avadel Pharmaceuticals PLC AVDL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Avadel Pharmaceuticals PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avadel Pharmaceuticals PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Avadel Pharmaceuticals PLC?

Muslim investors may consider investing in Avadel Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Avadel Pharmaceuticals PLC classified as HALAL?

Musaffa determines the Shariah status of Avadel Pharmaceuticals PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Avadel Pharmaceuticals PLC updated?

The Shariah compliance status of Avadel Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Avadel Pharmaceuticals PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Avadel Pharmaceuticals PLC?

You can check the latest Shariah compliance status of Avadel Pharmaceuticals PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AVDL Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Avadel Pharmaceuticals PLC is classified as halal.

HALAL

Report Source: 2025 3rd Quarter Report

Avadel Pharmaceuticals PLC. Stock Analysis AVDL

United States Health Care Mid Cap Report: Q3, 2025

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 188 full-time employees. The firm's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Key Statistics of Avadel Pharmaceuticals PLC (AVDL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$21.63$21.76

Today's Open

$21.66

Volume

35.02M

P/E Ratio (TTM)

52 Week Range

$6.38$23.57

Market Cap

2.11B

Avg. Volume

3.05M

Dividend Yield

Financial Metrics & Statements of Avadel Pharmaceuticals PLC (AVDL)

Super Investors Invested in Avadel Pharmaceuticals PLC (AVDL)

FAQ's for Avadel Pharmaceuticals PLC (AVDL)

As of July 2026, Avadel Pharmaceuticals PLC AVDL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avadel Pharmaceuticals PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in Avadel Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Avadel Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Avadel Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Avadel Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.